Quan Joanne 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Quan Joanne
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-01-16+12,500→ 12,618 total - Exercise/Conversion
Restricted Stock Units
2025-01-16−12,500→ 25,000 total→ Common Stock (12,500 underlying) - Sale
Common Stock
2025-01-17$45.86/sh−6,969$319,598→ 5,649 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F3]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.